Literature DB >> 18031519

Cardiac arrest and left ventricular fibrosis in a Finnish family with the lamin A/C mutation.

Eeva Hookana1, M Juhani Junttila, Terttu Särkioja, Raija Sormunen, Matti Niemelä, M J Pekka Raatikainen, Paavo Uusimaa, Eric Lizotte, Keijo Peuhkurinen, Ramon Brugada, Heikki V Huikuri.   

Abstract

INTRODUCTION: We screened the candidate genes from a Finnish family in which the mother was resuscitated from ventricular fibrillation and the daughter died suddenly without any prior cardiac symptoms. METHODS AND
RESULTS: In addition to screening of potential structural gene mutations, phenotyping of the proband and medico-legal autopsy of the victim of the sudden death, including histopathological examinations, were performed. Genetic screening revealed an R541C mutation in the lamin A/C gene both in the proband and her daughter. None of the 16 first- or second-degree relatives, or 96 unrelated healthy subjects, carried the same mutation. In the proband, the size and the global function of the left ventricle (LV) were normal, but a local hypokinesia and thinning of inferoposterior area of the LV were seen in 2D echocardiography and magnetic resonance imaging. Coronary angiogram and the results of the electrophysiological study were normal. Autopsy of the victim of sudden death showed localized thinning and fibrosis in the inferoposterior area of the LV, with only minimal fibrosis in the right ventricle and no abnormalities in the interventricular septum.
CONCLUSION: These observations indicate that a fatal or near-fatal cardiac arrhythmia can be the first clinical manifestation of a "de novo" mutation R541C of the lamin A/C gene. Replacement of cardiac myocytes by fibrosis seems to be the predominant pathologic-anatomic finding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031519     DOI: 10.1111/j.1540-8167.2007.01017.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.

Authors:  Samya Chakravorty; Babi Ramesh Reddy Nallamilli; Satish Vasant Khadilkar; Madhu Bala Singla; Ashish Bhutada; Rashna Dastur; Pradnya Satish Gaitonde; Laura E Rufibach; Logan Gloster; Madhuri Hegde
Journal:  Front Neurol       Date:  2020-11-05       Impact factor: 4.086

2.  What Should the Cardiologist know about Lamin Disease?

Authors:  Philippe Charron; Eloisa Arbustini; Gisèle Bonne
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

3.  Inherited dilated cardiomyopathy in a large Moroccan family caused by LMNA mutation.

Authors:  Najlae Adadi; Fatima Zohra Radi; Najim Lahrouchi; Loubna Hara; Ilham Ratbi; Siham Chafai Elalaoui; Marielle Alders; Jamila Zarzur; Connie Bezzina; Abdelaziz Sefiani
Journal:  Anatol J Cardiol       Date:  2018-07       Impact factor: 1.596

4.  Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?

Authors:  Przemyslaw Chmielewski; Ewa Michalak; Ilona Kowalik; Maria Franaszczyk; Malgorzata Sobieszczanska-Malek; Grazyna Truszkowska; Malgorzata Stepien-Wojno; Elzbieta Katarzyna Biernacka; Bogna Foss-Nieradko; Michal Lewandowski; Artur Oreziak; Maria Bilinska; Mariusz Kusmierczyk; Frédérique Tesson; Jacek Grzybowski; Tomasz Zielinski; Rafal Ploski; Zofia T Bilinska
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

5.  Case series: LMNA-related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement.

Authors:  Shuai Wang; Daoquan Peng
Journal:  ESC Heart Fail       Date:  2020-07-14

6.  Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype.

Authors:  Eystein T Skjølsvik; Nina E Hasselberg; Lars A Dejgaard; Øyvind H Lie; Kjell Andersen; Torbjørn Holm; Thor Edvardsen; Kristina H Haugaa
Journal:  J Am Heart Assoc       Date:  2020-01-20       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.